Delirium, Dementia, Amnestic, Cognitive Disorders  >>  sembragiline (RO4602522)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
sembragiline (RO4602522) / Roche, Evotec
NCT01701089: A Study of RO4602522 in Patients With Alzheimer Disease and in Healthy Volunteers

Completed
1
17
Europe
11C-L-deprenyl-D2, RO4602522
Hoffmann-La Roche
Healthy Volunteer, Alzheimer's Disease
05/13
05/13

Download Options